Kinnate Biopharma Inc.
Total Trades
9
Buys
9
Sells
0
Largest Trade
$1M+
Insiders
5
Institutional Funds
1
Inst. Value
$100K–$500K
Activist Filings
26
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Tananbaum James B. | Director | BUY | $1M+ | 1.8M | $2.80 | May 10, 2023 |
| Foresite Capital Management IV, LLC | 10% Owner | BUY | $1M+ | 1.8M | $2.80 | May 10, 2023 |
| ORBIMED ADVISORS LLC | Director | BUY | $1M+ | 1.5M | $2.80 | May 8, 2023 |
| GORDON CARL L | Director | BUY | $1M+ | 1.5M | $2.80 | May 8, 2023 |
| GORDON CARL L | Director | BUY | $1M+ | 1.4M | $2.61 | May 3, 2023 |
| ORBIMED ADVISORS LLC | Director | BUY | $1M+ | 1.4M | $2.61 | May 3, 2023 |
| Williams Richard Thomas | Chief Medical Offi… | BUY | $100K–$500K | 40K | $8.47 | Mar 15, 2022 |
| GORDON CARL L | Director | BUY | $1M+ | 196K | $10.17 | Feb 16, 2022 |
| ORBIMED ADVISORS LLC | Director | BUY | $1M+ | 196K | $10.17 | Feb 16, 2022 |
Institutional Ownership
13F filings as of Mar 31, 2024 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DEUTSCHE BANK AG\ | 115K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 13, 2024
0.0%
0 shares
Foresite Capital Fund IV, L.P. (“FCF IV”)
SC 13D/A · Apr 5, 2024
0.0%
0 shares
Foresite Capital Fund IV, L.P. (“FCF IV”)
SC 13D/A · Feb 22, 2024
20.5%
9.7M shares
SC 13D/A · Feb 21, 2024
16.1%
7.6M shares
Nextech V Oncology S.C.S., SICAV-SIF
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13G/A · Feb 14, 2024
5.5%
2.6M shares
SC 13G/A · Feb 14, 2024
4.2%
2.0M shares
SC 13G · Nov 27, 2023
6.3%
3.0M shares
SC 13D/A · Nov 17, 2023
16.0%
7.6M shares
Foresite Capital Fund IV, L.P. (“FCF IV”)
SC 13D/A · Nov 17, 2023
20.5%
9.7M shares
SC 13D/A · Nov 14, 2023
16.0%
7.6M shares
Foresite Capital Fund IV, L.P. (“FCF IV”)
SC 13D/A · Nov 14, 2023
20.5%
9.7M shares
SC 13G/A · Aug 14, 2023
0.0%
0 shares
Foresite Capital Fund IV, L.P. (“FCF IV”)
SC 13D/A · May 10, 2023
20.8%
9.7M shares
SC 13D/A · May 8, 2023
16.2%
7.6M shares
SC 13D/A · May 2, 2023
13.1%
6.1M shares
SC 13G/A · Apr 6, 2023
4.9%
2.3M shares
SC 13D/A · Feb 23, 2023
10.6%
4.7M shares
Foresite Capital Fund IV, L.P. (“FCF IV”)
SC 13D/A · Feb 22, 2023
20.8%
9.7M shares
SC 13G/A · Feb 14, 2023
9.7%
4.3M shares
Nextech V Oncology S.C.S., SICAV-SIF
SC 13G/A · Feb 14, 2023
5.3%
2.3M shares
SC 13G/A · Feb 13, 2023
5.0%
2.2M shares
SC 13G · Feb 3, 2023
5.3%
2.3M shares
SC 13G · Jan 23, 2023
5.0%
2.2M shares
SC 13G/A · Feb 14, 2022
8.2%
3.6M shares
SC 13G/A · Feb 10, 2022
6.3%
2.7M shares